Physical activity during cancer treatment (PACT) study

ISRCTN ISRCTN43801571
DOI https://doi.org/10.1186/ISRCTN43801571
Secondary identifying numbers NTR2138
Submission date
17/12/2009
Registration date
26/01/2010
Last edited
17/07/2020
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Petra Peeters
Scientific

Universitair Medisch Centrum Utrecht
Julius Center
PO Box 85500
Utrecht
3508 GA
Netherlands

Email p.h.m.peeters@umcutrecht.nl

Study information

Study designMulticentre pragmatic randomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleA randomised clinical trial of physical exercise during cancer treatment: the PACT study
Study acronymPACT
Study objectivesWe hypothesise that early physical exercise by reducing complaints of fatigue will lead to a reduction in sick leave and production losses. Altogether, we expect that physical exercise during cancer treatment will be cost-effective.
Ethics approval(s)Medical Ethics Committee of the University Medical Centre Utrecht, 27/02/2008, ref: 07/271/O
Health condition(s) or problem(s) studiedBreast cancer/colon cancer
InterventionDuring an intake, patients will be included, baseline measurements will be taken and patients will be randomly allocated to the intervention or control group. Participants assigned to the intervention group will receive usual care in combination with an 18-week supervised group exercise program. They will be encouraged to attend the exercise program two times a week supervised by a physiotherapist.

Participants who will be assigned to the control group will receive usual care, i.e., no exercise intervention.

We will assess the short term as well as the long term effects. Short-term effects will be measured 18 weeks after inclusion (at the end of the program) and long term effects will be measured 9 months after inclusion.
Intervention typeBehavioural
Primary outcome measureMeasured at baseline, 18 weeks and 9 months:
1. Fatigue
2. Health service utilisation and sick leave
Secondary outcome measuresMeasured at baseline, 18 weeks and 9 months:
1. Health related quality of life
2. Anxiety and depression
3. Physical fitness
4. Body composition
5. Cognitive behavioural aspects
6. Physical activity level
Overall study start date01/01/2010
Completion date31/12/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants300
Total final enrolment92
Key inclusion criteria1. Recently diagnosed with breast or colon cancer (stage M0): histological diagnosis of cancer less than six (breast cancer) or ten (colon cancer) weeks ago
2. Treated with chemotherapy
3. Aged 25 - 75 years, either sex
4. Able to read and understand the Dutch language
5. Karnovsky Performance Status of 60 or higher
6. Able to walk 100 metres or more
Key exclusion criteria1. Treated for cancer in the past five years (except basal skin cancer)
2. Contraindications for physical activity (Revised Physical Activity Readiness Questionnaire)
Date of first enrolment01/01/2010
Date of final enrolment31/12/2012

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Universitair Medisch Centrum Utrecht
Utrecht
3508 GA
Netherlands

Sponsor information

The Netherlands Organisation for Health Research and Development (ZonMw) (Netherlands)
Research organisation

Laan van Nieuw Oost Indië 334
Den Haag
2593 CE
Netherlands

Email rossum@zonmw.nl
Website http://www.zonmw.nl/
ROR logo "ROR" https://ror.org/01yaj9a77

Funders

Funder type

Research organisation

Netherlands Organisation for Health Research and Development
Private sector organisation / Other non-profit organizations
Alternative name(s)
Netherlands Organisation for Health Research and Development
Location
Netherlands

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 09/06/2010 Yes No
Results article results 08/06/2015 Yes No
Results article results 01/05/2016 Yes No
Results article results 08/05/2019 10/01/2020 Yes No
Results article follow up results 16/04/2020 17/07/2020 Yes No

Editorial Notes

17/07/2020: Publication reference added.
10/01/2020: Publication reference and total final enrolment number added.
20/01/2017: Publication reference added.